Available 24/7

Seven Days A Week

720.372.2824

Call Us For A Free Consultation

Facebook

Twitter

LinkedIn

 
FDAzar > Attorneys > Joshua E. Moyer

Joshua E. Moyer

Mr. Moyer is an attorney in the Class Action Group at Franklin D. Azar & Associates and focuses his practice on securities and ERISA class action lawsuits. Currently, he represents investors in a securities class action against Edward D. Jones & Co., L.P. and 401(k) plan participants in an ERISA class action against CenturyLink, Inc.

Before joining FDAzar, Mr. Moyer worked on a variety of multi-party, multi-district, and complex litigations and contributed to the successful prosecution of cases protecting the rights of shareholders, defending market integrity and recovering millions of dollars. Such cases include In Re Forex Antitrust, Case No. 13-cv-7789 (alleging manipulation of dozens of foreign exchange rates over decades, in violation of the Sherman Antitrust Act, 15 U.S.C. §§1, 3, and the Commodity Exchange Act, 7 U.S.C. §§1; over $1.1B in settlements recovered to date) and In re National Prescription Opiate Litigation., No. 17-md-02804 (N.D. Ohio Jan. 4, 2018) (alleging the use of Big Tobacco-style marketing of prescription drugs by several pharmaceutical companies to increase sales, leading to widespread addiction and otherwise avoidable deaths).

Other cases in which Mr. Moyer contributed to the recovery of funds for shareholders include: Schuh v. HCA Holdings, Inc., No. 3:11-cv-01033 (M.D. Tenn.) (§§11, 12(a)(2) & 15 of the Securities Act of 1933 claims, $215M recovery); In re Bridgepoint Educ., Inc. Sec. Litigation., No. 3:12-CV-1737 JM (WMC), 2013 U.S. Dist. LEXIS 131423 (S.D. Cal. Sept. 13, 2013) (§§10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934, $15.5M recovery); Low v. Trump University LLC and Donald J. Trump , No. 10-cv-0940 GPC-WVG (S … .D. Cal.)/Cohen v. Donald J. Trump, No. 13-cv-2519-GPC-WVG (S.D. Cal.) ($21M recovery); Willis v. Big Lots, Inc., et al., Case No. 2:12-cv-604, Opinion and Order (S.D. Ohio Mar. 17, 2017) ($38M recovery); and In re ViroPharma Incorporated Securities Litigation, Civil Action No. 2:12-02714 (E.D. Penn) ($8M recovery).

Mr. Moyer was also part of the teams of attorneys obtaining class certification in the pending case of Hsingching Hsu v. Puma Biotechnology, Inc. (Trial set for 2018), which alleges violations of the Securities Exchange Act of 1934. He also contributed to the prosecution of two ongoing antitrust cases involving the manipulation of the price of commodities on a global scale: In re Liquid Aluminum Sulfate Antitrust Litigation., No. 2:16-md-02687 (S.D.N.Y.) and In Re Aluminum Antitrust, 13-md-2481 (KBF) and all related cases.

Mr. Moyer received his Bachelor of Arts degree from Ursinus College in 2001, where he was awarded All-American and Academic All-American honors as a student-athlete, and his Juris Doctorate from the University of San Diego School of Law in 2008, where he assisted low-income clients at the USD Legal Clinic and clerked for the San Diego District Attorney’s Office. He is admitted to the State Bar of California and is licensed to practice in all state and U.S. District Courts for the District of California.